Landscapes / Targets
EBV
11 drugs act on EBV, in 13 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs11
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
On the market | 22 Aug 2028Phase 4 trial completes | |||
| Next date | 22 Aug 2028 · Phase 4 trial completes | ||||
| Open drug page | |||||
Cell therapy |
Pierre Fabre Medicament +1 |
Phase 3 | Jun 2027Phase 2 trial completes | ||
| How it works | A cell therapy | ||||
| Next date | Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Solid Organ Transplant Complications, Lymphoproliferative Disorders and 3 more | ||||
| Open drug page | |||||
— |
Moderna · Public MRNA |
Phase 1/2 | 15 May 2027Phase 1 trial completes | ||
| Next date | 15 May 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1/2 | 4 Jun 2027Phase 1/2 trial completes | |||
| Next date | 4 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | BKV Infection, CMV Infection | ||||
| Open drug page | |||||
— |
Phase 1/2 | Sep 2027Phase 1/2 trial completes | |||
| Next date | Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Genital Neoplasm, Female and 11 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Merck & Co. · Public MRK |
Phase 1/2 | 31 Mar 2029Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 31 Mar 2029 · Phase 1/2 trial completes | ||||
| Also tested for | B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and 10 more | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2027Phase 1 trial completes | |||
| Next date | Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Mature B-Cell Neoplasm, Non Hodgkin Lymphoma and 23 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 1 | 29 Feb 2028Phase 1 trial completes | ||
| Next date | 29 Feb 2028 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2028Phase 1 trial completes | |||
| Next date | Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | B Cell Lymphoma, NHL, Adult and 24 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Included
- Burkitt Lymphoma, Infectious Mononucleosis · Breakdown
- Covers
- 11 of 28 active trials the registry tags as Epstein-Barr Virus Infections (39%)
- Checked
- 11 of 11 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026